Related Experiment Video
Updated: Aug 16, 2026

13:01
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 24, 2014
Serum protein markers in systemic lupus erythematosus
S Rantapää Dahlqvist1, G Beckman, L Beckman
1Department of Medical Genetics, University of Umeå, Sweden.
Human Heredity
|January 1, 1988
Summary
Systemic lupus erythematosus (SLE) patients show higher rates of complement C4 deficiency and haptoglobin type 2-2. These findings suggest potential genetic markers for SLE susceptibility.
Area of Science:
- Immunogenetics
- Rheumatology
- Clinical Biochemistry
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a significant genetic component.
- Complement system deficiencies, particularly in C4, have been implicated in SLE pathogenesis.
- Serum protein polymorphisms may serve as genetic markers for SLE risk.
Purpose of the Study:
- To investigate the association between specific serum protein markers and SLE.
- To determine the prevalence of complement C4 deficiency and haptoglobin types in SLE patients compared to healthy controls.
Main Methods:
- Analysis of serum protein markers including alpha 1-antitrypsin (alpha 1-AT), Bf, C3, C4A, C4B, haptoglobin (Hp), and transferrin (Tf).
- Comparison of marker frequencies between 36 SLE patients and normal blood donors.
- Calculation of relative risks for specific genetic polymorphisms (e.g., C4 AQ0 and BQ0 homozygosity).
Main Results:
- A significant increase in complement C4 deficiency was observed in SLE patients (relative risks of 7.2 for AQ0 and 4.1 for BQ0 homozygosity).
- Simultaneous occurrence of C4 AQ0 and BQ0 homozygosity presented a high relative risk (approximately 65) in SLE patients.
- Haptoglobin type 2-2 was significantly more prevalent in SLE patients (p < 0.05).
- No significant associations were found for other studied serum protein systems (alpha 1-AT, Bf, C3, Tf).
Conclusions:
- Complement C4 deficiency is strongly associated with SLE, particularly specific homozygous genotypes.
- Haptoglobin type 2-2 may also be a risk factor for developing SLE.
- These serum protein polymorphisms could serve as valuable genetic markers for SLE susceptibility.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.

